Pfizer’s Unbroken Payout Streak Provides Backdrop as VanEck Dividend Fund Surges Past €8.1bn
28.06.2026 - 05:12:33 | boerse-global.de
A powerful rotation out of US tech stocks and into reliable dividend payers has catapulted the VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF to a new asset peak. The fund now manages €8.1 billion, a record that underscores how investors are piling into global income generators as volatility rattles the equity market.
The shift has been dramatic. Just over a year ago, assets under management were a fraction of today’s total. The appetite for steady cash flows, combined with a deliberate pullback from American mega-caps, has turned the ETF into one of the fastest-growing vehicles in the dividend space.
Pfizer’s unbroken run embodies the fund’s core filter. The pharmaceutical giant has declared its 351st consecutive quarterly dividend at $0.43 per share for the third quarter, with an ex-date of 24 July and payment due on 1 September 2026. As a 3.63% portfolio weighting, Pfizer is among the top holdings and directly contributes to the fund’s income profile. The ETF’s screening rules demand that every constituent must have paid a dividend in the past twelve months, kept its payout per share at or above the level of five years ago, and maintained a forward payout ratio below 75%. From the surviving universe, the 100 highest-yielding names are selected.
The fund closed last week at €51.98, virtually flat on the session but up 23.79% on a 12-month basis. The relative strength index sits at a neutral 47, offering no overbought or oversold signals. The price is marginally below the 50-day moving average of €52.33, while the 52-week high of €54.48 remains 4.59% above the current level. The long-term trend, however, is intact, and the latest distribution of €0.81 per share, paid on 10 June, points to a forward dividend yield of roughly 3.18%.
All eyes are on Thursday’s US employment report for June. The data will shape expectations for Federal Reserve policy directly, and for a fund dominated by interest-rate-sensitive sectors, the stakes are high. Financials command 31.58% of the portfolio, energy 17.89%, and healthcare 15.28%. A strong jobs print would keep rate-cut hopes in check, which typically supports financial and energy stocks — precisely the two largest sector bets in the ETF. At the same time, robust economic momentum would underpin the earnings power that energy and consumer staples need to sustain their own payouts.
That macro picture got a subtle boost from the Conference Board’s Leading Economic Index. The index rose 0.1% in May, the second consecutive increase, and the six-month rate of deceleration slowed to just 0.3% — a marked improvement from the 1.3% pace recorded in the prior half-year. The data suggests the economy is not softening as quickly as many had feared.
VanEck has also responded to the investor shift by launching a new sister fund. The TDVX, domiciled in Ireland and launched in April, excludes US equities entirely and accumulates rather than distributes dividends. That accumulation feature was not feasible in the original Dutch fund for regulatory reasons. With an annual fee of 0.38%, the new vehicle tilts even more heavily toward financials such as Zurich Insurance, while telecom stocks take a smaller role. Both ETFs use the same strict dividend-quality screen.
The 100-stock portfolio’s cost of 0.38% places it in the cheapest fifth of Morningstar’s global equity income category, where the median expense ratio stands at 1.06%. That fee advantage, combined with the relentless demand for income in a rate-uncertain world, has drawn fresh inflows every month this year.
Thursday’s jobs number will be the next catalyst. A solid reading could push the fund’s financial and energy heavyweights even higher, while a miss might reignite rate-cut bets that benefit interest-rate-sensitive names. Either way, the ETF’s rules-based construction means it will continue to track the highest dividend payers that pass its historical consistency test — and Pfizer’s 351-quarter streak is a powerful reminder that for this fund, consistency is everything.
Ad
VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF Stock: New Analysis - 28 June
Fresh VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Read our updated VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF analysis...
